Since established in 2000, Suzhou Lixin Pharmaceutical Co., Ltd. has been aimed at developing the global normative dominant market of characteristic APIs and advanced intermediates, driven by technological innovation, taken the path of sustainable development, and gradually formed the pharmaceutical product lines including anti-tumor, cardiovascular, antiviral and digestive system and other areas. Lixin has already become the high-quality supplier of many global pharmaceutical companies and has established the long-term relationship with a number of well-known domestic and foreign pharmaceutical companies to achieve win-win cooperation.
Products & Services
Dacarbazine
Hydrochlorothiazide
Idebenone
Idebenone non-sterile
Sites
Suzhou Lixin Pharmaceutical Co., Ltd
Audited
Country
People's Republic of ChinaCity
Suzhou
Address
塘西路 21, 215011